全文获取类型
收费全文 | 395294篇 |
免费 | 10585篇 |
国内免费 | 561篇 |
专业分类
耳鼻咽喉 | 4044篇 |
儿科学 | 13307篇 |
妇产科学 | 8551篇 |
基础医学 | 48132篇 |
口腔科学 | 8728篇 |
临床医学 | 26158篇 |
内科学 | 80378篇 |
皮肤病学 | 7554篇 |
神经病学 | 34349篇 |
特种医学 | 14344篇 |
外国民族医学 | 30篇 |
外科学 | 55022篇 |
综合类 | 3359篇 |
一般理论 | 38篇 |
预防医学 | 41986篇 |
眼科学 | 7943篇 |
药学 | 25959篇 |
中国医学 | 1483篇 |
肿瘤学 | 25075篇 |
出版年
2023年 | 1152篇 |
2022年 | 1696篇 |
2021年 | 4301篇 |
2020年 | 2373篇 |
2019年 | 4389篇 |
2018年 | 27589篇 |
2017年 | 20769篇 |
2016年 | 23084篇 |
2015年 | 5408篇 |
2014年 | 6494篇 |
2013年 | 9180篇 |
2012年 | 20087篇 |
2011年 | 34267篇 |
2010年 | 25658篇 |
2009年 | 17278篇 |
2008年 | 30421篇 |
2007年 | 33158篇 |
2006年 | 12275篇 |
2005年 | 13594篇 |
2004年 | 13906篇 |
2003年 | 14131篇 |
2002年 | 11903篇 |
2001年 | 7082篇 |
2000年 | 7754篇 |
1999年 | 6068篇 |
1998年 | 1669篇 |
1997年 | 1252篇 |
1996年 | 1065篇 |
1992年 | 3132篇 |
1991年 | 2971篇 |
1990年 | 2953篇 |
1989年 | 2532篇 |
1988年 | 2335篇 |
1987年 | 2173篇 |
1986年 | 2170篇 |
1985年 | 2027篇 |
1984年 | 1487篇 |
1983年 | 1298篇 |
1979年 | 1588篇 |
1978年 | 1074篇 |
1975年 | 1156篇 |
1974年 | 1445篇 |
1973年 | 1460篇 |
1972年 | 1374篇 |
1971年 | 1322篇 |
1970年 | 1282篇 |
1969年 | 1344篇 |
1968年 | 1323篇 |
1967年 | 1173篇 |
1966年 | 1070篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
José Luis R Martin Víctor Pérez Montse Sacristán Fernando Rodríguez-Artalejo Cristóbal Martínez Enric Alvarez 《European psychiatry》2006,21(1):11-20
OBJECTIVE: To assess antipsychotic medication in the treatment of schizophrenia, based on trial drop-out rates. METHOD: The studies included were randomised controlled trials that compared any of the four clinically best-established atypical antipsychotics (quetiapine, olanzapine, risperidone or clozapine) against either of two typical antipsychotics regarded as the gold standard (haloperidol or chlorpromazine). RESULTS: Meta-analysis indicated less risk of all-cause patient withdrawal from atypical medication trials where dosage was flexible, in both the short, relative risk (RR) 0.70 (95% CI 0.64-0.76), P<0.00001, and long term, RR 0.72 (0.65-0.80), P<0.00001. Similar results were observed for withdrawal due to adverse events, RR: 0.54 (0.41-0.72), P<0.0001. Nevertheless, the favourable effects of atypical medication disappeared in trials relying on fixed dosage. CONCLUSIONS: We detected a significant positive effect in terms of the outcome of treatment discontinuation for atypical versus typical medication, though only where the use of flexible rather than fixed doses (closer to an experimental control situation) was possible. 相似文献
92.
Lipid peroxidation, occupational stress and aging in workers of a prehospital emergency service. 总被引:2,自引:0,他引:2
Angela Casado Nieves De Lucas Encarnación López-Fernández Alberto Sánchez José-Antonio Jimenez 《European journal of emergency medicine》2006,13(3):165-171
BACKGROUND: Stressful conditions lead to formation of excessive free radicals, and lipid peroxidation is one of the major outcomes of free radical-mediated injury that directly damages membranes and generates a number of secondary products. OBJECTIVES: To determine the levels of malondialdehyde, an end product of lipid peroxidation, according to demographic and occupational variables in workers of a prehospital emergency service and to analyse the relationship between malondialdehyde levels and burnout. MATERIAL AND METHODS: One hundred and eleven healthy workers of a prehospital emergency service and eighty aged-matched healthy individuals of both sexes as a control group were surveyed. Malondialdehyde levels were measured by the Bull and Marnett method. To measure burnout, the Maslach Burnout Inventory was used. RESULTS: Professional category is associated with lipid peroxidation and burnout levels (Malondialdehyde levels were: physicians 338.10+/-14.47, nurses 329.17+/-12.62 and technicians 296.74+/-14.28; burnout levels were: physicians 41.29+/-3.59, nurses 37.38+/-6.05 and technicians 35.33+/-5.87). Working at night and in the evening increased malondialdehyde and burnout levels. Malondialdehyde levels increase with age. No significant variations with respect to sex were detected. Significant variations in malondialdehyde levels were detected between singles (303.13+/-12.74) and married people (344.43+/-13.43) but not with respect to divorcees (326.44+/-11.74). Significant differences were detected in erythrocyte malondialdehyde levels between smokers (341.37+/-17.09) and nonsmokers (302.21+/-12.38), but not for alcohol consumption. CONCLUSIONS: These findings suggest a positive correlation between malondialdehyde, a biomarker of lipid peroxidation and occupational stress, as estimated by elements of the Maslach Burnout Inventory, and oxidative stress. 相似文献
93.
94.
95.
96.
97.
O Schouten J H H van Laanen E Boersma R Vidakovic H H H Feringa M Dunkelgrün J J Bax J Koning H van Urk D Poldermans 《European journal of vascular and endovascular surgery》2006,32(1):21-26
OBJECTIVE: To evaluate the effect of statins on aneurysm growth in a group of consecutive patients under surveillance for infrarenal aortic aneurysms (AAA). MATERIALS AND METHODS: All patients (59 statin users, 91 non-users) under surveillance between January 2002 and August 2005 with a follow-up for aneurysm growth of at least 12 months and a minimum of three diameter evaluations were retrospectively included in the analysis. Multiple regression analysis, weighted with the number of observations, was performed to test the influence of statins on AAA growth rate. RESULTS: During a median period of 3.1 (1.1-13.1) years the overall mean aneurysm growth rate was 2.95+/-2.8 mm/year. Statin users had a 1.16 mm/year lower AAA growth rate compared to non-users (95% CI 0.33-1.99 mm/year). Increased age was associated with a slower growth (-0.09 mm/year per year, p = 0.003). Female gender (+1.82 mm/year, p = 0.008) and aneurysm diameter (+0.06 mm/year per mm, p = 0.049) were associated with increased AAA growth. The use of non-steroidal anti-inflammatory drugs, chronic lung disease, or other cardiovascular risk factors were not independently associated with AAA growth. CONCLUSIONS: Statins appear to be associated with attenuation of AAA growth, irrespective of other known factors influencing aneurysm growth. 相似文献
98.
99.
C. M. Crceles J. M. Serrano P. Marín E. Escudero E. Fernndez‐Varn 《Transboundary and Emerging Diseases》2006,53(6):300-304
The pharmacokinetics (PK) of moxifloxacin in healthy white New Zealand rabbits was studied following intravenous (IV) and subcutaneous (SC) administration routes as well as a SC long‐acting poloxamer 407 gel formulation (SC‐P407). Moxifloxacin concentrations were determined by high‐performance liquid chromatography assay with fluorescence detection. Mean half‐life for IV, SC and SC‐P407 routes was 2.15, 5.41 and 11.09 h. Clearance value after IV dosing was 0.78 l/kg/h. After SC administration, the mean absolute bioavailability was 117% and the Cmax was 1.61 ± 0.49 mg/l. After SC‐P407 administration, the bioavailability was 44% and the Cmax 1.83 was ±0.62 mg/l. No adverse effects were observed in any of the rabbits following IV, SC and SC‐P407 administration of moxifloxacin. Minimal inhibitory concentrations of moxifloxacin against different strains of Staphylococcus aureus from different european countries were used to compute the main pharmacodynamic (PD) surrogate markers of efficacy. The high tolerability of this SC‐P407 formulation and the favourable PK behaviour such as the long half‐life, acceptable bioavailability and excellent PK–PD ratios achieved indicate that it is likely to be effective in rabbits. 相似文献
100.